Oriowo M A, Ruffolo R R
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pa.
J Vasc Res. 1992 Jan-Feb;29(1):33-40. doi: 10.1159/000158929.
The effects of chlorethylclonidine, WB 4101 and nifedipine on norepinephrine-induced contractions of rat, guinea-pig, rabbit and dog aortae were investigated in order to characterize the alpha 1-adrenoceptor subtype(s) present in the aortae of these different species. The putative alpha 1A-adrenoceptor antagonist, WB 4101, was significantly more potent in the rat aorta compared to the rabbit, guinea-pig and dog aortae which were not significantly different from each other. The calcium channel antagonist, nifedipine (1 microM), had little or no effect on norepinephrine-induced contractions in aortic segments from the rabbit, guinea pig and dog; whereas in the rat aorta, nifedipine significantly inhibited the response to norepinephrine. Based on the studies with WB 4101 and nifedipine, alpha 1-adrenoceptors in rat aorta would be tentatively classified as alpha 1A-adrenoceptors, whereas those in the guinea-pig, rabbit and dog aortae would be of the alpha 1B-adrenoceptor subtype. The putative irreversible alpha 1B-adrenoceptor antagonist, chlorethylclonidine, inhibited the response to norepinephrine in aortae from all species, but to dramatically different degrees. The response to norepinephrine was inhibited by 500-fold and 450-fold by chlorethylclonidine in the rat and dog aortae, respectively, whereas in the guinea-pig and rabbit aortae, the potency of norepinephrine was reduced by only 3- and 20-fold, respectively. Thus, based on studies with chlorethylclonidine, alpha 1-adrenoceptors in the rat and dog aortae would be classified as alpha 1B-adrenoceptors (i.e., chlorethylclonidine-sensitive), whereas alpha 1A-adrenoceptors (chlorethylclonidine-insensitive) would predominate in the guinea-pig aorta, and possibly both alpha 1A- and alpha 1B-adrenoceptors would coexist in the rabbit aorta.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了氯乙可乐定、WB 4101和硝苯地平对去甲肾上腺素诱导的大鼠、豚鼠、兔和犬主动脉收缩的影响,以表征这些不同物种主动脉中存在的α1-肾上腺素能受体亚型。与兔、豚鼠和犬主动脉相比,推定的α1A-肾上腺素能受体拮抗剂WB 4101在大鼠主动脉中的效力显著更高,而后三者之间无显著差异。钙通道拮抗剂硝苯地平(1微摩尔)对兔、豚鼠和犬主动脉段中去甲肾上腺素诱导的收缩几乎没有影响;而在大鼠主动脉中,硝苯地平显著抑制对去甲肾上腺素的反应。基于对WB 4101和硝苯地平的研究,大鼠主动脉中的α1-肾上腺素能受体可初步归类为α1A-肾上腺素能受体,而豚鼠、兔和犬主动脉中的α1-肾上腺素能受体则为α1B-肾上腺素能受体亚型。推定的不可逆α1B-肾上腺素能受体拮抗剂氯乙可乐定抑制了所有物种主动脉对去甲肾上腺素的反应,但程度差异很大。氯乙可乐定在大鼠和犬主动脉中分别将对去甲肾上腺素的反应抑制了500倍和450倍,而在豚鼠和兔主动脉中,去甲肾上腺素的效力仅分别降低了3倍和20倍。因此,基于对氯乙可乐定的研究,大鼠和犬主动脉中的α1-肾上腺素能受体将被归类为α1B-肾上腺素能受体(即对氯乙可乐定敏感),而α1A-肾上腺素能受体(对氯乙可乐定不敏感)在豚鼠主动脉中占主导地位,兔主动脉中可能同时存在α1A-和α1B-肾上腺素能受体。(摘要截短于250字)